A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation

Subjects

Subjects :

Transplantation
Molecular Medicine
Immunology and Allergy
Cell Biology
Hematology

Details

ISSN :

26666367

Volume :

29

Database :

OpenAIRE

Journal :

Transplantation and Cellular Therapy

Accession number :

edsair.doi...........a7e9159bb9c3b6a6c2fac1c9f45a73bd

Full Text :

https://doi.org/10.1016/j.jtct.2023.02.010